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ABSTRACT
Our recent studies have shown that naturally occurring dietary organo sulfure compounds such as di allyl sulfide
and paclitaxel are capable of inhibiting polycyclic aromatic hydrocarbon (PAH) metabolism and subsequent PAH-
DNA adduct formation in Wistar rats. In this study these plant phenols were tested for their effects against PAHs
and 7,12 Di Methyl Benz (A) Anthracene -induced skin tumorigenesis in rats. Each compounds was evaluated as a
possible anticarcinogen in an initiation and promotion and a complete skin tumorigenesis protocol. In the two-stage
tumor  protocol in Wistar rats  using  7,12-dimethylbenz(a)anthracene   as the  initiating  agent followed  by  twice
weekly applications of acetone as tumor promoter each plant compounds afforded significant protection against skin
tumorigenicity. The protective effects were verified both by prolongation of latency period and by subsequent tumor
development.  Our  results  suggest  that  these  plants  compounds  have  substantial  though  variable  potential  for
modifying the risk of skin tumorigenicity induced by a wide variety of chemicals and of these combinations of
Paclitaxel and Di allyl sulfide was shown to have maximal chemo protective effects.
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INTRODUCTION
Skin  cancer  is  the  most  common  form  of  human
cancer.  It is estimated that over 1 million new cases
occur annually.
1,2 The annual rates of all forms of skin
cancer  are  increasing  each  year,  representing  a
growing public concern. It has also been estimated that
nearly half of all Americans who live to age 65 will
develop skin cancer at least once
3. The most common
warning  sign  of  skin  cancer  is  a  change  in  the
appearance of the skin, such as a new growth or a sore
that  will  not  heal. In  India,  skin  cancers  constitute
about  1-2%  of  all  diagnosed  cancers.  Basal  cell
carcinoma  is  the  commonest  form  of  skin  cancer
worldwide,  but  various  studies  from  India  have
consistently reported SCC as the most prevalent skin
malignancy
4. Although complete data of incidence is
not  available,  various  cancer  registries  in  India
reported cumulative incidence of skin cancer varying
from 0.5 to 2 per 100 000 population
5. Although, the
incidence of  skin  cancers  in  India  is  lower  as
compared  to  the  Western  world,  because  of  a  large
population, absolute number of cases is estimated to be
significant.  Skin  cancer  patients  have  stage  IV
receive  chemotherapy  and  /or  hormonal  therapy  to
suppress cancer cells and control the disease. The goal
of chemotherapy is to destroy, shrink primary tumors,
slow the tumor growth, and to kill cancer cells that
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may have spread (metastasized) to other parts of the
body from the original tumor. Chemotherapeutic drugs
elicit  some  toxicity  towards  normal  cells  also,  that
limits its usage.
Paclitaxel is a naturally occurring antineoplastic agent
has shown great promise in the therapeutic treatment
of  certain  human  solid  tumors  particularly  in
metastatic breast cancer, skin cancer, lung cancer and
refractory  ovarian  cancer
6.  Paclitaxel's  antitumor
activity was discovered in1960’s during a large scale
35,000  plants-screening  program  sponsored  by  the
National Cancer Institute (NCI), USA. Paclitaxel is a
most  effective  drug  in  skin  cancer,  it  has  several
important  side  affects  particularly  neutropenia,
peripheral neuropathy and hypersensitivity reactions
7.
Myelo suppression or neutropenia is the principal dose
limiting  toxicity  of  paclitaxel  on  all  administration
schedules. It is undeniable that the need for new agents
with  both  improved  activity  and  acceptable  safety
profile is urgent. Nausea, vomiting, thrombocytopenia,
mucositis, decreased appetite and diarrhea are the less
common  side  effects  of  administration  of  paclitaxel.
Ongoing  clinical  trials  suggest  that  combining
paclitaxel  with  other  anticancer  drugs  may  be  an
effective  treatment  for  patients  with  skin  cancer.
Researchers  are  exploring  ways  to  reduce  the  side
effects  of  treatment  improve  the  quality  of  patients'
lives, and reduce pain.
The  chemotherapeutic  and  antitumor  activity
associated  with  garlic  has  been  attributed  to  the
presence  of  various  organosulfide-based  active
compounds  including  Di  Allyl  sulfide
6.  A  topical
application of Di allyl sulfide is the most promising
approach  for  treating  skin  tumors  as  it  leads  to  a
localized effect at the desired site with minimal side
effects.    Polycyclic  aromatic  hydrocarbons  (PAHs)
are  commonly  occurring  environmental
contaminants  and  are  widely  distributed  in  the
environment  as  pollutants  of  air,  water  and  soil
8.
Benzo  (a)  pyrene  is  the  most  toxic  compound  of
PAHs.
9
The  purpose  of  the  present  study  is  to  evaluate  the
combined  effect  of  Paclitaxel  and  Di  allyl  sulfide
against the DMBA induced skin carcinogenesis.
MATERIALS AND METHODS
Chemicals: 7,12 Dimethyl benz (a) anthracene and Di
allyl  sulfide  were  purchased  from  Sigma  chemical
company, USA. All the other chemicals used were of
analytical grade.
Animal  care  and  housing: Male Wistar rats,  6-8
weeks of age and weighing 150-200g, were used. The
animals  were  procured  from  Central  Animal  House
Block,  Meenakshi  Medical  College  and  Research
institute,  Kanchipuran,  Tamil  Nadu,  India and
maintained in a controlled environmental condition of
temperature  and  humidity  on  alternatively  12  h
light/dark cycles. All animals were fed standard pellet
diet (Gold Mohor rat feed, Ms.Hindustan Lever Ltd.,
Mumbai) and water ad libitum. This research work on
Wistar male rats was sanctioned and approved by the
Institutional Animal Ethical Committee
Experimental Design
The animals were divided in to six groups of 6 animals
each.
Group I animals served as control,
Group II as animals treated with DMBA (5 µg/kg of
body weight) per animal in acetone (100 µL), three
times  a  week  for  28  weeks  to  induce  skin  cancer.
After tumor induction:
Group  III animals  were  treated  with  Paclitaxel
(33mg/kg b.wt) once in a week for 4 weeks in intra
muscular.
Group IV animals were treated with garlic extract of
Di allyl sulfide (250µg/animal) for 30 days daily.
Group V animals were treated with both Paclitaxel and
Di allyl sulfide (as in group III and group IV) daily.
After the experimental period of 32 weeks, the animals
were  sacrificed  by  cervical  dislocation.  Blood  sample
was collected via cardiac puncture, and add 2-3drops of
EDTA anticoagulant.
The following Biochemical analysis was done:
1. Estimation of total white blood cells:
Enumerated by the method of John (1972)
10
2. Differential Leucocyte count: By the method of
John (1972)
10
3. Soluble immune complex was estimated by the
method of Seth and Srinivas (1981)
11
4. Nitro blue tetrazolium (NBT) reduction test:
was carried out by the method of gifford and
malavista (1970)
12
5. Neutrophil function test: By the method of
Wilkinson (1977)
13
6. Ig G was quantitatively measured: by Tenant et al
(1979)
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7. Phagocytic index: by the method of Wilkinson
(1977)
13.
8. Avidity index: by the method of Wilkinson
(1977)
13.
RESULTS
Immunocompetent cells : Fig. 1 represents the effect
of paclitaxel  and  Di  allyl  sulfide  on  the  status  of
immunocompetent  cells  in  various  experimental
groups.  Group  II  cancer  bearing  animals  show  a
significant (p<0.001) decrease in the cell counts when
compared with group I control animals. Paclitaxel  and
Di allyl sulfide treatment caused a significant decrease
in  leucocytes  (p<0.05),  lymphocyte  (p<0.01),
neutrophils  (p<0.01),  absolute  lymphocyte  count
(p<0.05)  and  absolute  neutrophil  count  (p<0.05). Di
Allyl  Sulfide along  with  paclitaxel treated  group  V
animals  caused  a  considerable  changes  (p<0.001;
p<0.01) in cell count. However the effect was more
pronounced in the group VI  animals treated with both
paclitaxel and Di allyl sulfide when compared with
group I control animals.
Fig 1: Effect of paclitaxel and Di allyl sulfide on the status of immunocompetent cells
Immune  complexes: Fig.  2  depicts  the  effect  of
paclitaxel and Di Allyl Sulfide on immune complexes
like  phagocytic  index,  avidity  complex,  NBT
reduction  and  SIC  in  various  experimental  groups.
Group II cancer bearing animals showed a significant
(p<0.001)  decrease  in  the  immune  complexes  when
compared  with  group  I  control  animals.  Paclitaxel
treatment  caused  a  significant  (p<0.01;  p<0.05)
decrease  in  the  levels  of  immune  complexes.  Upon
paclitaxel and Di allyl sulfide treatment there found to
be  a  significant  (p<0.001;  p<0.01)  increase  in  the
levels of immune complexes.
Fig 2: Effect of paclitaxel and Di Allyl Sulfide on immune complexes
Units - Total leucocyte count : cu mm x 10
2; Lymphocyte : % ;  Neutrophils : %; Absolute lymphocyte count :
mm
3 x 10
2
Absolute neutrophil count : no/mm
3 / 10
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Immunoglobulins
Fig 3 display the levels of immunoglobulins like IgG,
IgA,  and Ig  M  in  various  experimental  groups.  IgG
and IgM levels were decreased considerably (p<0.001)
in cancer bearing group  II animals with an increase
(p<0.001) in IgA level when compared with group I
control animals. Upon paclitaxel treatment the levels
of  IgG,  IgM  were  significantly  (p<0.05)  decreased
where as IgA level was increased (p<0.01) in group III
animals. Di allyl sulfide along with paclitaxel treated
group  V  animals  showed  considerable  alterations  in
the  levels  of  Immunoglobulins  (p<0.001)  when
compared  with  group  II  cancer  bearing  animals.  In
group VI animals treated with both paclitaxel and Di
allyl  sulfide show  no  significant  changes  when
compared with group I control animals.
Fig 3: Levels of immunoglobulins like IgG, IgA, and Ig M in various experimental groups.
DISCUSSION
Immunomodulatory  activities: Chemotherapy
remains the major hope for the treatment of cancer and
is always associated with some degree of haemopoietic
tissue  toxicity  and  immune  suppression.  Although
cancer  itself  is  immunosuppressive,  cytotoxic
antineoplatic therapy is the primary contributor to the
clinical immunodeficiency observed in cancer patients.
Severe  leucopenia,  thrombocytopenia  alterations  in
circulating platelets, white and red blood cells are the
main  side  effects  of  chemotherapy  leading  to  the
decrease of chemotherapy dose or discontinuation of
treatment.
15 The  most  common  complication
associated with cytotoxic antineoplatic therapy occurs
with the onset of neutropenia.
16 Though paclitaxel is a
potent anticancer agent the major limiting side effect is
myelosuppression. It induces troublesome neutropenia
of grade 3-4 with decrease in WBC count in more than
50% of the patients.
Abnormal  content  of  immunoglobulin  indicate  the
concised humoral immunity and reduction in immune
response. Thompson et a.l
17 have reported decreased
levels of IgG and IgM in skin cancer conditions. The
levels of IgG and IgM were also decreased in various
other cancerous conditions.
18-20 IgA content alone was
found to be increased in the skin cancer bearing rats.
Chandy et al
21, have reported that the elevated serum
IgA  levels  may  be  due  to  the  failure  of  clearance
mechanism  by  the  damaged  liver. This  indicates the
severity of liver damage which directly correlates with
the progression of the disease.
A significant alteration in the neutrophil functions has
been observed in all our study. The killing ability of
the neutroplil as indicated by the NBT reduction and
phagocytic  ability  of the neutrophils  as indicated  by
the phagocytic index and the avidity index has been
significantly decreased in the cancer bearing animals
which  was  further  decreased  upon  treatment  with
paclitaxel.
Soluble  serum  immune  complexes  serve  as  an
indicator of immune responses either due to presence
of excess antigens or antibodies. This may be due to
decreased  antibody  production during  cancer.
Immunomodulation  through  natural  or  synthetic
substances may be considered as an alternative for the
prevention  and  cure  of  neoplastic  diseases.
22,  23
Flavanoids are polyphenol substances of plant origin,
having  biological  and  antioxidative properties.
24
Several reports have demonstrated the beneficial effect159
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of  flavanoids  in  preventing  toxicity  of  different
agents.
25-27
Flavanoids display a remarkable array of biochemical
and pharmacologiocal actions some of which suggest
that  certain  members  of  this  group  of  compounds
significantly affect the function of the immune system.
They  also  affect  the  function  of  enzyme  system
critically  involved  in  the  immune  system.  Di  allyl
sulfide contains organo sulfur compounds that play a
very important role in scavenging free radicals. In our
study also Di allyl sulfide exhibited positive effect on
the  immune  system  which  can  be  attributed  to  its
flavanoid content. Ali et al. (2000) have reported that
Di  allyl  sulfide  stimulates  immune  response  in  rats.
Mesbah Lahouel
28 have reported the effect of Di allyl
sulfide  on haemotoxicity of chemotherapeutic drugs.
Considering the possible mode of antitumor action of
Di allyl sulfide it is likely that it could be mediated by
immunomodulatory  activity  of  Di  allyl  sulfide.  The
present study has given the hope that Di allyl sulfide
can  confer  in  the  reduction  of  side  effects  due  to
chemotherapeutic agents and may be used in humans
in future.
CONCLUSION
From the present study, the effect of Paclitaxel- DAS
combination proved to be effective chemotherapeutic
agent  against  DMBA  induced  skin  cancer  in  wistar
rats compared to that of paclitaxel or Di allyl sulfide
confirmed    analyzing  the    total  white  blood  cells,
Differential  leukocyte  count,  Soluble  immune
complex,  neutophil  function  tests,  IgG,  IgM,  IgA
levels  and  Phagocytic  ,  Avidity  indexs  in  blood
samples
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